About Exalenz Bioscience
Exalenz Bioscience is a company based in Modi'in-maccabim-re'ut (Israel) founded in 2006 was acquired by Meridian Bioscience in February 2020. Exalenz Bioscience operates in a competitive market with competitors including Mauna Kea Tech, EchoSens, CapsoVision, Smart Medical Systems and Invendo Medical, among others.
- Headquarter Modi'in-maccabim-re'ut, Israel
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Meridian Bioscience
(Feb 19, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Exalenz Bioscience
Detailed funding history for Exalenz Bioscience
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Exalenz Bioscience
Exalenz Bioscience has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Meridian Bioscience.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Molecular diagnostic device and kits
|
Locked | Locked | Locked |
Investor details for Exalenz Bioscience
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Exalenz Bioscience
Investment portfolio details for Exalenz Bioscience
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Exalenz Bioscience
Detailed financials for Exalenz Bioscience
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Exalenz Bioscience Comparisons
Peer comparison for Exalenz Bioscience
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Exalenz Bioscience
Exalenz Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Mauna Kea Tech, EchoSens, CapsoVision, Smart Medical Systems and Invendo Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Endomicroscopy devices are developed for gastrointestinal and respiratory endoscopy.
|
|
| Locked | Locked | Locked |
Non-invasive diagnostics for liver disease detection are developed.
|
|
| Locked | Locked | Locked |
GI capsule endoscopy systems are developed for intestinal imaging.
|
|
| Locked | Locked | Locked |
Endoscopes and devices for GI diagnosis and treatment are produced.
|
|
| Locked | Locked | Locked |
Sterile single-use robotics-based endoscopes are developed for gastroenterology.
|
|
| Locked | Locked | Locked |
Devices for GI disorder diagnosis and treatment are developed.
|
Detailed competitors of Exalenz Bioscience
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Exalenz Bioscience
Complete news archive for Exalenz Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Exalenz Bioscience
Exalenz Bioscience was founded in 2006.
Exalenz Bioscience is headquartered in Modi'in-maccabim-re'ut, Israel. It is registered at Modi'in-maccabim-re'ut, Central District, Israel.
Exalenz Bioscience was founded in 2006 and focuses on medical diagnostics in the gastrointestinal and liver disorder sector. Non-invasive breath analysis systems are developed and commercialized by the company to identify H. pylori bacteria, a key factor in peptic ulcers and gastric cancer risks. Hepatocellular cancer monitoring is also enabled by the technology. Regulatory approvals have been obtained in the USA, Europe, and China, with tests completed in 10-15 minutes.
Exalenz Bioscience's top competitors include EchoSens, CapsoVision and Mauna Kea Tech.
Exalenz Bioscience has 1 investor. Key investors include Meridian Bioscience.